|
Executive Order on Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients
|
|
Executive Order on Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients is an executive order (EO) signed by U.S. president Donald Trump on May 12, 2025. The order aims to reduce the cost of prescription drugs by directing federal agencies to link U.S. prices to the lower prices paid for the same drugs in a group of other developed countries. This approach is referred to as "most favored nation" (MFN) pricing, likening it to certain trade deals. Content Trump signed Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, an executive order, on May 12, 2025. He stated that the policy would reduce prescription drug prices significantly and end the U.S. "subsidizing the health care of foreign countries." He claimed prices could fall by 30% to 80% or even more. The order directs the Department of Health and Human Services to communicate price targets to pharmaceutical manufacturers and, if necessary, pursue rulemaking to impose MFN pricing across the U.S. healthcare system, including commercial markets, Medicare, and Medicaid. Pharmaceutical industry executives and Republican representatives warned that reducing drug prices could stifle innovation. See Also
|
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
